JP5656996B2 - 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 - Google Patents

工学的に作製されたエアロゾル粒子、およびそれに関連した方法 Download PDF

Info

Publication number
JP5656996B2
JP5656996B2 JP2012520713A JP2012520713A JP5656996B2 JP 5656996 B2 JP5656996 B2 JP 5656996B2 JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012520713 A JP2012520713 A JP 2012520713A JP 5656996 B2 JP5656996 B2 JP 5656996B2
Authority
JP
Japan
Prior art keywords
particles
engineered
body member
particle
processed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012520713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532739A5 (enExample
JP2012532739A (ja
Inventor
ジョセフ エム． デジモン，
ジョセフ エム． デジモン，
ベンジャミン メイナー，
ベンジャミン メイナー，
メアリー ネピアー，
メアリー ネピアー，
ジョナサン ピライ，
ジョナサン ピライ，
フィリップ デジモン，
フィリップ デジモン，
ウィル パトリック，
ウィル パトリック，
カイル レーカー，
カイル レーカー，
ハンジュン チャン，
ハンジュン チャン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Original Assignee
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill filed Critical University of North Carolina at Chapel Hill
Publication of JP2012532739A publication Critical patent/JP2012532739A/ja
Publication of JP2012532739A5 publication Critical patent/JP2012532739A5/ja
Application granted granted Critical
Publication of JP5656996B2 publication Critical patent/JP5656996B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/22—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by pressing in moulds or between rollers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2012520713A 2009-07-13 2010-07-13 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 Expired - Fee Related JP5656996B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22513809P 2009-07-13 2009-07-13
US61/225,138 2009-07-13
PCT/US2010/041797 WO2011008737A2 (en) 2009-07-13 2010-07-13 Engineered aerosol particles, and associated methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014182213A Division JP6189807B2 (ja) 2009-07-13 2014-09-08 工学的に作製されたエアロゾル粒子、およびそれに関連した方法

Publications (3)

Publication Number Publication Date
JP2012532739A JP2012532739A (ja) 2012-12-20
JP2012532739A5 JP2012532739A5 (enExample) 2013-08-15
JP5656996B2 true JP5656996B2 (ja) 2015-01-21

Family

ID=42818752

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012520713A Expired - Fee Related JP5656996B2 (ja) 2009-07-13 2010-07-13 工学的に作製されたエアロゾル粒子、およびそれに関連した方法
JP2014182213A Active JP6189807B2 (ja) 2009-07-13 2014-09-08 工学的に作製されたエアロゾル粒子、およびそれに関連した方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014182213A Active JP6189807B2 (ja) 2009-07-13 2014-09-08 工学的に作製されたエアロゾル粒子、およびそれに関連した方法

Country Status (4)

Country Link
US (1) US20120114554A1 (enExample)
EP (1) EP2454011A2 (enExample)
JP (2) JP5656996B2 (enExample)
WO (1) WO2011008737A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9057712B1 (en) 2011-10-27 2015-06-16 Copilot Ventures Fund Iii Llc Methods of delivery of encapsulated perfluorocarbon taggants
WO2013082111A2 (en) * 2011-11-29 2013-06-06 The University Of North Carolina At Chapel Hill Geometrically engineered particles and methods for modulating macrophage or immune responses
US11505648B2 (en) * 2015-04-21 2022-11-22 Ran Biotechnologies, Inc. Fluorinated surfactants
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
BR112018009899A8 (pt) 2015-11-18 2019-02-26 Glaxosmithkline Ip No 2 Ltd composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose.
CN105790924B (zh) * 2016-04-28 2018-11-02 滁州博明信息科技有限公司 一种具有Lorenz型吸引子的简单混沌系统电路
IL262720B2 (en) 2016-05-05 2024-06-01 Liquidia Tech Inc Dry powder treprostinil for the treatment of pulmonary hypertension
EP3455219A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
AU2017290593A1 (en) 2016-06-27 2019-01-03 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
CN118440096A (zh) 2017-06-20 2024-08-06 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
KR20210018199A (ko) 2018-03-26 2021-02-17 씨4 테라퓨틱스, 인코포레이티드 이카로스의 분해를 위한 세레블론 결합제
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
US11814391B2 (en) 2018-09-06 2023-11-14 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
US20250197403A1 (en) 2020-02-20 2025-06-19 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
AU2021231898A1 (en) 2020-03-05 2022-10-27 C4 Therapeutics, Inc. Compounds for targeted degradation of BRD9
CN116437913A (zh) 2020-09-23 2023-07-14 艾其林医药公司 用于治疗补体介导的病症的药物化合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
AU6130594A (en) 1991-03-05 1994-08-15 Miris Medical Corporation Method and device for correcting the drift offset of a pressure sensor of a flowmeter
CA2112674C (en) 1991-07-02 2005-10-04 John S. Patton Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
CZ289029B6 (cs) 1994-09-21 2001-10-17 Inhale Therapeutic Systems Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu
US5780014A (en) 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US7704684B2 (en) * 2003-12-01 2010-04-27 The Board Of Trustees Of The University Of Illinois Methods and devices for fabricating three-dimensional nanoscale structures
KR101281775B1 (ko) 2003-12-19 2013-07-15 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 소프트 또는 임프린트 리소그래피를 이용하여 분리된마이크로- 및 나노- 구조를 제작하는 방법
WO2007030698A2 (en) * 2005-09-07 2007-03-15 The University Of North Carolina At Chapel Hill Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality
WO2006130943A1 (en) * 2005-06-10 2006-12-14 The Governors Of The University Of Alberta Respirable dried powder formulation comprising drug loaded nanoparticles
AU2006282042B2 (en) * 2005-06-17 2011-12-22 The University Of North Carolina At Chapel Hill Nanoparticle fabrication methods, systems, and materials
EP1951202A4 (en) * 2005-11-07 2013-03-06 Univ North Carolina ISOLATED AND SOLID MICRO AND NANO STRUCTURES AND METHOD THEREFOR
WO2008011051A1 (en) * 2006-07-17 2008-01-24 Liquidia Technologies, Inc. Nanoparticle fabrication methods, systems, and materials
US20100055459A1 (en) * 2006-08-30 2010-03-04 Liquidia Technologies, Inc. Nanoparticles Having Functional Additives for Self and Directed Assembly and Methods of Fabricating Same
US7875654B2 (en) * 2007-03-23 2011-01-25 The Board Of Trustees Of The University Of Illinois System for forming janus particles

Also Published As

Publication number Publication date
WO2011008737A3 (en) 2011-06-23
WO2011008737A8 (en) 2011-08-11
EP2454011A2 (en) 2012-05-23
US20120114554A1 (en) 2012-05-10
JP2015027504A (ja) 2015-02-12
JP6189807B2 (ja) 2017-08-30
WO2011008737A2 (en) 2011-01-20
JP2012532739A (ja) 2012-12-20

Similar Documents

Publication Publication Date Title
JP6189807B2 (ja) 工学的に作製されたエアロゾル粒子、およびそれに関連した方法
Malamatari et al. Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation
CA2611985C (en) Nanoparticle fabrication methods, systems, and materials
Zhang et al. Microfluidic methods for fabrication and engineering of nanoparticle drug delivery systems
Anton et al. Trojan microparticles for drug delivery
Champion et al. Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers
US9040090B2 (en) Isolated and fixed micro and nano structures and methods thereof
JP2012532739A5 (enExample)
Behara et al. Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications
Song et al. Controllable formation of monodisperse polymer microbubbles as ultrasound contrast agents
US20160038418A1 (en) Nanoparticle fabrication methods, systems, and materials
Altobelli et al. Micro-and nanocarriers by electrofludodynamic technologies for cell and molecular therapies
Bohr et al. Preparation of nanoscale pulmonary drug delivery formulations by spray drying
Negi et al. Engineering inhalable therapeutic particles: conventional and emerging approaches
Duong Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery
US20130295143A1 (en) Electroprocessing of active pharmaceutical ingredients
WO2007094829A2 (en) Isolated and fixed micro and nano structures and methods thereof
Li Alginate-based inhalable particles for controlled pulmonary drug delivery
WO2007030698A2 (en) Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality
Garg et al. Characterizing particulate drug-delivery carriers with atomic force microscopy
Jahangiri et al. Carrier-free inhalable dry microparticles of celecoxib: use of the electrospraying technique
Albetawi Current research on spray-dried chitosan nanocomposite microparticles for pulmonary drug delivery
US20160136093A9 (en) Engineered aerosol particles, and associated methods
Kaushik et al. PCL–DOX microdroplets: an evaluation of the enhanced intracellular delivery of doxorubicin in metastatic cancer cells via in silico and in vitro approaches
Faramarzi et al. Polymeric pharmaceutical nanoparticles developed by electrospray

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130701

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130701

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140805

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140908

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20141029

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20141125

R150 Certificate of patent or registration of utility model

Ref document number: 5656996

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees